Related Experiment Video
Updated: Apr 10, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
Glioblastoma Circulating Cells: Reality, Trap or Illusion?
A Lombard1, N Goffart2, B Rogister3
1Laboratory of Developmental Neurobiology, GIGA-Neuroscience, University of Liège, Liège, Belgium ; Department of Neurosurgery, CHU and University of Liège, Liège, Belgium.
Glioblastoma multiforme (GBM) cells may spread through the bloodstream, contributing to deadly recurrence. Understanding circulating tumor cells (CTCs) and their epithelial to mesenchymal transition (EMT) could offer new GBM treatment strategies.
Area of Science:
- Oncology
- Cancer Biology
- Neuro-oncology
Background:
- Metastasis, the spread of cancer cells, is a key factor in cancer mortality.
- Glioblastoma multiforme (GBM) typically recurs locally, but GBM cells have been detected in the bloodstream.
- The role of circulating tumor cells (CTCs) in GBM recurrence and metastasis is under investigation.
Purpose of the Study:
- To review the molecular mechanisms of circulating tumor cells (CTCs).
- To emphasize the role of epithelial to mesenchymal transition (EMT) in CTC properties.
- To explore the potential involvement of CTCs and EMT in Glioblastoma multiforme (GBM) recurrence and metastasis.
Main Methods:
- Literature review of existing studies on circulating tumor cells (CTCs).
- Analysis of molecular mechanisms, particularly epithelial to mesenchymal transition (EMT).
- Speculative analysis of CTCs' relevance in Glioblastoma multiforme (GBM) pathogenesis.
Main Results:
- Circulating tumor cells (CTCs) possess properties enabling survival and dissemination.
- Epithelial to mesenchymal transition (EMT) is a crucial mechanism for CTCs' invasive and migratory capabilities.
- The presence and properties of GBM cells in circulation suggest a potential role in metastatic recurrence.
Conclusions:
- Circulating GBM cells, through mechanisms like EMT, may contribute to tumor recurrence.
- Understanding CTCs and EMT is critical for developing novel therapeutic strategies against GBM.
- Further research into CTCs in GBM could unlock new avenues for combating this aggressive brain cancer.
More Related Videos
12:25Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry
Published on: January 7, 2014
09:36Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion
Published on: August 29, 2018